Reumatóide. Portaria SAS/MS. n. 865, 2002.
MONTASSER, I.; BRIANÇON, S.; LIETO, J.; FESSI, H. Méthodes d’obtention
et mécanismes de formation de nanopartícules polymériques. J. Pharm. Belg.,
55(6): 155-167, 2000.
MORELAND, L.W.; SCHIFF, M.H.; BAUMGARTNER, S.W.; TINDALL, E.A.;
FLEISCHMANN, R.M.; BULPITT, K.J.; WEAVER, A.L.; KEYSTONE, E.C.;
FURST, D.E.; MEASE, P.J.; RUDERMAN, E.M.; HORWITZ, D.A.; ARKFELD,
D.G.; GARRISON, L.; BURGE, D.J.; BLOSCH, C.M.; LANGE, M.L.;
MCDONNELL, N.D.; WEINBLATT, M.E. Etanercept therapy in rheumatoid
rthritis. A randomized, controlled trial. Ann. Intern. Med., 130(6): 478-86, 1999.
MUCHTAR, S.; ALMOG, S.; TORRACA, M.T.; SAETTONE, M.F.; BENITA, S.
Ophthalm. Res. 24: 142-9, 1992.
MUCHTAR, S.; BENITA, S. Colloids Surf. 91: 181-90, 1994.
MÜLLER, M.; RASTELLI, C.; FERRI, P.; JANSEN, B.; BREITENEDER, H.;
EICHLER, H. Transdermal Penetration of diclofenac after multiple epicutaneous
administration. The Journal of Rheumatology. 25(9): 1833-1836, 1998.
MUKHERJEE S.; GHOSH, R.N.; MAXFIELD, F.R. Endocytosis. Physiol Rev.
77:759–803, 1997.
MULLER-LADNER, U.; PAP, T.; GAY, R.E.; NEIDHART, M. GAY.S.
Mechanisms of desease: the molecular and cellular basis of joint destruction in
rheumatoid arthritis. Nature. 1(2), 2005.
NAGAKURA, Y.; OKADA, M.; KOHARA, A.; KISO, T.; TOYA, T.; IWAI, A.;
WANIBUCHI, F.; YAMAGUCHI, T. Allodynia and Hyperalgesia in Adjuvant-
Induced Arthritic rats: Time course of progression and efficacy of analgesics.
The Journal of Pharmacology and Experimental Therapeutics. 12: 167-181,
2003.
NAVEH, N.; WEISSMAN, C.; MUCHTAR, S.; BENITA, S.; MECHOULAM, R.
Graefe’s Arch. Clin. Exp. Ophthalmol. 238: 334-8, 2000.
NISHIHATA, T.; KOTERA, K.; NAKANO, Y.; YMAZAKI, M. Rat percutaneous
transport of diclofenac and influence of hydrogenated soya phospholipids.
Chemical pharmaceutical bulletin. 35(9): 809-3812, 1987.
PALAZZI, C.; OLIVIERI, I.; D’AMICO, E.; PENNESE, E.; PETRICCA, A.
Management of reactive arthritis. Expert. Opin. Pharmacother., 5(1): 61-70,
2004.
PARDEIKE, J.; HOMMOS, A.; MÜLLER, R.H. Lipid nanoparticles (SLN, NLC) in
cosmetic and pharmaceutical dermal products. International Journal of
Pharmaceutics. 366: 170-184, 2009.